Source:http://linkedlifedata.com/resource/pubmed/id/11906780
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions |
umls-concept:C0005210,
umls-concept:C0011570,
umls-concept:C0026336,
umls-concept:C0030685,
umls-concept:C0034693,
umls-concept:C0034721,
umls-concept:C0036751,
umls-concept:C0221099,
umls-concept:C0391871,
umls-concept:C0680255,
umls-concept:C0871261,
umls-concept:C1283071,
umls-concept:C1704632,
umls-concept:C1706817,
umls-concept:C1963578,
umls-concept:C2911692
|
pubmed:issue |
3
|
pubmed:dateCreated |
2002-3-21
|
pubmed:abstractText |
Involvement of both the serotonergic and the endogenous opioid systems in the onset of depressive behavior has been suggested. Previously we showed that serotonin (5-hydroxytryptamine) facilitates beta-endorphin release in the nucleus accumbens (NAcc). Herein, the microdialysis method was used to assess in vivo the effects of serotonin on beta-endorphin release in a rat model of depressive behavior (the Flinders sensitive line, FSL), before and after antidepressant treatment. The basal extracellular level of beta-endorphin in the NAcc of FSL rats did not differ significantly from that in control rats. However, serotonin-induced beta-endorphin release was impaired in FSL rats. Chronic treatment (18 days) with desipramine or paroxetine did not significantly affect the extracellular levels of beta-endorphin in the NAcc of either the FSL or control rats. However, the chronic antidepressant treatment did normalize the serotonin-induced release of beta-endorphin in FSL rats, as well as their behavioral manifestation of depressive behavior. Our results show that depressive behavior may relate to an impaired effect of serotonin on beta-endorphin release in the NAcc in a rat model of depression, and suggest a possible new mode of action of antidepressant drugs.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0306-4522
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
110
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
389-93
|
pubmed:dateRevised |
2009-11-3
|
pubmed:meshHeading |
pubmed-meshheading:11906780-Animals,
pubmed-meshheading:11906780-Antidepressive Agents, Tricyclic,
pubmed-meshheading:11906780-Depression,
pubmed-meshheading:11906780-Disease Models, Animal,
pubmed-meshheading:11906780-Dose-Response Relationship, Drug,
pubmed-meshheading:11906780-Extracellular Space,
pubmed-meshheading:11906780-Male,
pubmed-meshheading:11906780-Neural Pathways,
pubmed-meshheading:11906780-Neurons,
pubmed-meshheading:11906780-Nucleus Accumbens,
pubmed-meshheading:11906780-Rats,
pubmed-meshheading:11906780-Rats, Sprague-Dawley,
pubmed-meshheading:11906780-Serotonin,
pubmed-meshheading:11906780-Serotonin Uptake Inhibitors,
pubmed-meshheading:11906780-Synaptic Transmission,
pubmed-meshheading:11906780-beta-Endorphin
|
pubmed:year |
2002
|
pubmed:articleTitle |
Impaired release of beta-endorphin in response to serotonin in a rat model of depression.
|
pubmed:affiliation |
Faculty of Life Sciences, Bar-Ilan University, Ramat-Gan, Israel.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|